nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—colon cancer	0.47	1	CbGaD
Telaprevir—ALB—Irinotecan—colon cancer	0.0643	0.231	CbGbCtD
Telaprevir—ALB—Fluorouracil—colon cancer	0.0617	0.221	CbGbCtD
Telaprevir—Urate nephropathy—Vincristine—colon cancer	0.043	0.347	CcSEcCtD
Telaprevir—ALB—Methotrexate—colon cancer	0.034	0.122	CbGbCtD
Telaprevir—ABCB1—Irinotecan—colon cancer	0.0336	0.121	CbGbCtD
Telaprevir—ABCB1—Vincristine—colon cancer	0.0294	0.106	CbGbCtD
Telaprevir—CYP3A4—Irinotecan—colon cancer	0.0201	0.0723	CbGbCtD
Telaprevir—ABCB1—Methotrexate—colon cancer	0.0178	0.0639	CbGbCtD
Telaprevir—CYP3A4—Vincristine—colon cancer	0.0176	0.0632	CbGbCtD
Telaprevir—ORM1—bile—colon cancer	0.0127	0.107	CbGeAlD
Telaprevir—CMA1—blood vessel—colon cancer	0.0111	0.0936	CbGeAlD
Telaprevir—CTSK—gall bladder—colon cancer	0.00673	0.0567	CbGeAlD
Telaprevir—CTSS—gall bladder—colon cancer	0.0059	0.0497	CbGeAlD
Telaprevir—Proctitis—Fluorouracil—colon cancer	0.00568	0.0459	CcSEcCtD
Telaprevir—CMA1—smooth muscle tissue—colon cancer	0.00521	0.0439	CbGeAlD
Telaprevir—CMA1—lymphoid tissue—colon cancer	0.00416	0.0351	CbGeAlD
Telaprevir—CMA1—digestive system—colon cancer	0.00411	0.0347	CbGeAlD
Telaprevir—CMA1—bone marrow—colon cancer	0.00379	0.0319	CbGeAlD
Telaprevir—CTSS—embryo—colon cancer	0.00374	0.0315	CbGeAlD
Telaprevir—Boceprevir—ABCB1—colon cancer	0.00365	1	CrCbGaD
Telaprevir—ORM1—gall bladder—colon cancer	0.00352	0.0297	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—colon cancer	0.00336	0.0283	CbGeAlD
Telaprevir—CTSK—renal system—colon cancer	0.00323	0.0272	CbGeAlD
Telaprevir—ALB—gall bladder—colon cancer	0.00309	0.026	CbGeAlD
Telaprevir—CMA1—liver—colon cancer	0.00306	0.0258	CbGeAlD
Telaprevir—CTSS—smooth muscle tissue—colon cancer	0.00294	0.0248	CbGeAlD
Telaprevir—CTSS—renal system—colon cancer	0.00283	0.0239	CbGeAlD
Telaprevir—Lymphopenia—Irinotecan—colon cancer	0.00283	0.0229	CcSEcCtD
Telaprevir—CTSK—lymphoid tissue—colon cancer	0.00268	0.0226	CbGeAlD
Telaprevir—CTSK—digestive system—colon cancer	0.00265	0.0223	CbGeAlD
Telaprevir—CTSK—bone marrow—colon cancer	0.00244	0.0206	CbGeAlD
Telaprevir—CTSS—lymphoid tissue—colon cancer	0.00235	0.0198	CbGeAlD
Telaprevir—CMA1—lymph node—colon cancer	0.00235	0.0198	CbGeAlD
Telaprevir—CTSK—vagina—colon cancer	0.00234	0.0197	CbGeAlD
Telaprevir—CTSS—digestive system—colon cancer	0.00232	0.0196	CbGeAlD
Telaprevir—Pruritus genital—Capecitabine—colon cancer	0.00232	0.0188	CcSEcCtD
Telaprevir—CTSS—bone marrow—colon cancer	0.00214	0.018	CbGeAlD
Telaprevir—Proctalgia—Capecitabine—colon cancer	0.00207	0.0167	CcSEcCtD
Telaprevir—CTSS—vagina—colon cancer	0.00205	0.0173	CbGeAlD
Telaprevir—Swelling face—Capecitabine—colon cancer	0.00204	0.0165	CcSEcCtD
Telaprevir—Retinal disorder—Methotrexate—colon cancer	0.00202	0.0163	CcSEcCtD
Telaprevir—CTSK—liver—colon cancer	0.00197	0.0166	CbGeAlD
Telaprevir—Lymphopenia—Capecitabine—colon cancer	0.00189	0.0153	CcSEcCtD
Telaprevir—CTSS—liver—colon cancer	0.00173	0.0146	CbGeAlD
Telaprevir—Haemorrhoids—Capecitabine—colon cancer	0.00165	0.0133	CcSEcCtD
Telaprevir—Hyperuricaemia—Vincristine—colon cancer	0.0016	0.013	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Irinotecan—colon cancer	0.00159	0.0129	CcSEcCtD
Telaprevir—Oral candidiasis—Capecitabine—colon cancer	0.00153	0.0123	CcSEcCtD
Telaprevir—Blood uric acid increased—Vincristine—colon cancer	0.00151	0.0122	CcSEcCtD
Telaprevir—CTSK—lymph node—colon cancer	0.00151	0.0128	CbGeAlD
Telaprevir—Hypothyroidism—Capecitabine—colon cancer	0.00151	0.0122	CcSEcCtD
Telaprevir—CTSS—lymph node—colon cancer	0.00133	0.0112	CbGeAlD
Telaprevir—ORM1—bone marrow—colon cancer	0.00128	0.0108	CbGeAlD
Telaprevir—Renal failure acute—Irinotecan—colon cancer	0.00114	0.00921	CcSEcCtD
Telaprevir—ABCB1—blood vessel—colon cancer	0.00111	0.00932	CbGeAlD
Telaprevir—Rectal haemorrhage—Capecitabine—colon cancer	0.00107	0.00868	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Capecitabine—colon cancer	0.00107	0.00862	CcSEcCtD
Telaprevir—ORM1—liver—colon cancer	0.00103	0.0087	CbGeAlD
Telaprevir—Blood creatinine increased—Irinotecan—colon cancer	0.000985	0.00796	CcSEcCtD
Telaprevir—Hypokalaemia—Irinotecan—colon cancer	0.000957	0.00773	CcSEcCtD
Telaprevir—Candida infection—Capecitabine—colon cancer	0.000925	0.00748	CcSEcCtD
Telaprevir—ALB—liver—colon cancer	0.000906	0.00763	CbGeAlD
Telaprevir—Eosinophilia—Fluorouracil—colon cancer	0.000862	0.00697	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000794	0.00641	CcSEcCtD
Telaprevir—ORM1—lymph node—colon cancer	0.000792	0.00667	CbGeAlD
Telaprevir—Hyperuricaemia—Methotrexate—colon cancer	0.000778	0.00629	CcSEcCtD
Telaprevir—Infestation NOS—Fluorouracil—colon cancer	0.000776	0.00627	CcSEcCtD
Telaprevir—Infestation—Fluorouracil—colon cancer	0.000776	0.00627	CcSEcCtD
Telaprevir—Renal failure acute—Capecitabine—colon cancer	0.000762	0.00616	CcSEcCtD
Telaprevir—Urinary tract disorder—Vincristine—colon cancer	0.000738	0.00596	CcSEcCtD
Telaprevir—Blood uric acid increased—Methotrexate—colon cancer	0.000735	0.00594	CcSEcCtD
Telaprevir—Urethral disorder—Vincristine—colon cancer	0.000732	0.00592	CcSEcCtD
Telaprevir—CYP3A4—renal system—colon cancer	0.000706	0.00595	CbGeAlD
Telaprevir—ALB—lymph node—colon cancer	0.000694	0.00585	CbGeAlD
Telaprevir—ABCB1—embryo—colon cancer	0.00066	0.00556	CbGeAlD
Telaprevir—Blood creatinine increased—Capecitabine—colon cancer	0.000659	0.00533	CcSEcCtD
Telaprevir—Hypokalaemia—Capecitabine—colon cancer	0.00064	0.00518	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000634	0.00512	CcSEcCtD
Telaprevir—Anaemia—Vincristine—colon cancer	0.000601	0.00486	CcSEcCtD
Telaprevir—Anaemia—Irinotecan—colon cancer	0.000585	0.00473	CcSEcCtD
Telaprevir—CYP3A4—digestive system—colon cancer	0.000579	0.00488	CbGeAlD
Telaprevir—Syncope—Irinotecan—colon cancer	0.000568	0.00459	CcSEcCtD
Telaprevir—Renal failure acute—Methotrexate—colon cancer	0.000567	0.00459	CcSEcCtD
Telaprevir—Anaemia—Fluorouracil—colon cancer	0.00056	0.00453	CcSEcCtD
Telaprevir—Loss of consciousness—Irinotecan—colon cancer	0.000556	0.0045	CcSEcCtD
Telaprevir—Infestation NOS—Capecitabine—colon cancer	0.000542	0.00438	CcSEcCtD
Telaprevir—Infestation—Capecitabine—colon cancer	0.000542	0.00438	CcSEcCtD
Telaprevir—ABCB1—epithelium—colon cancer	0.000538	0.00454	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000538	0.00435	CcSEcCtD
Telaprevir—Infection—Vincristine—colon cancer	0.000527	0.00426	CcSEcCtD
Telaprevir—Nervous system disorder—Vincristine—colon cancer	0.00052	0.00421	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—CDX2—colon cancer	0.00052	0.0909	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Vincristine—colon cancer	0.000519	0.0042	CcSEcCtD
Telaprevir—Infection—Irinotecan—colon cancer	0.000513	0.00415	CcSEcCtD
Telaprevir—Hepatobiliary disease—Capecitabine—colon cancer	0.000513	0.00415	CcSEcCtD
Telaprevir—Shock—Irinotecan—colon cancer	0.000508	0.00411	CcSEcCtD
Telaprevir—Nervous system disorder—Irinotecan—colon cancer	0.000507	0.0041	CcSEcCtD
Telaprevir—Thrombocytopenia—Irinotecan—colon cancer	0.000506	0.00409	CcSEcCtD
Telaprevir—ABCB1—renal system—colon cancer	0.000499	0.00421	CbGeAlD
Telaprevir—Infection—Fluorouracil—colon cancer	0.000492	0.00397	CcSEcCtD
Telaprevir—Nervous system disorder—Fluorouracil—colon cancer	0.000485	0.00392	CcSEcCtD
Telaprevir—Thrombocytopenia—Fluorouracil—colon cancer	0.000485	0.00392	CcSEcCtD
Telaprevir—Urinary tract disorder—Capecitabine—colon cancer	0.000481	0.00389	CcSEcCtD
Telaprevir—Oedema peripheral—Capecitabine—colon cancer	0.00048	0.00388	CcSEcCtD
Telaprevir—Urethral disorder—Capecitabine—colon cancer	0.000477	0.00386	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000472	0.00381	CcSEcCtD
Telaprevir—Erythema multiforme—Capecitabine—colon cancer	0.00046	0.00372	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vincristine—colon cancer	0.000458	0.0037	CcSEcCtD
Telaprevir—Fatigue—Vincristine—colon cancer	0.000457	0.0037	CcSEcCtD
Telaprevir—Eye disorder—Capecitabine—colon cancer	0.000455	0.00368	CcSEcCtD
Telaprevir—Eosinophilia—Methotrexate—colon cancer	0.000448	0.00362	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000446	0.00361	CcSEcCtD
Telaprevir—Fatigue—Irinotecan—colon cancer	0.000445	0.0036	CcSEcCtD
Telaprevir—CYP3A4—liver—colon cancer	0.000431	0.00363	CbGeAlD
Telaprevir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000427	0.00345	CcSEcCtD
Telaprevir—Malnutrition—Capecitabine—colon cancer	0.000424	0.00343	CcSEcCtD
Telaprevir—Dysgeusia—Capecitabine—colon cancer	0.000415	0.00335	CcSEcCtD
Telaprevir—ABCB1—lymphoid tissue—colon cancer	0.000415	0.00349	CbGeAlD
Telaprevir—ABCB1—digestive system—colon cancer	0.00041	0.00345	CbGeAlD
Telaprevir—Infestation NOS—Methotrexate—colon cancer	0.000404	0.00326	CcSEcCtD
Telaprevir—Infestation—Methotrexate—colon cancer	0.000404	0.00326	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.0004	0.00324	CcSEcCtD
Telaprevir—Urticaria—Fluorouracil—colon cancer	0.000393	0.00318	CcSEcCtD
Telaprevir—Anaemia—Capecitabine—colon cancer	0.000392	0.00317	CcSEcCtD
Telaprevir—Hepatobiliary disease—Methotrexate—colon cancer	0.000382	0.00309	CcSEcCtD
Telaprevir—Asthenia—Vincristine—colon cancer	0.000381	0.00308	CcSEcCtD
Telaprevir—Syncope—Capecitabine—colon cancer	0.00038	0.00307	CcSEcCtD
Telaprevir—ABCB1—bone marrow—colon cancer	0.000378	0.00318	CbGeAlD
Telaprevir—Loss of consciousness—Capecitabine—colon cancer	0.000372	0.00301	CcSEcCtD
Telaprevir—Asthenia—Irinotecan—colon cancer	0.000371	0.003	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—colon cancer	0.000363	0.00293	CcSEcCtD
Telaprevir—ABCB1—vagina—colon cancer	0.000362	0.00305	CbGeAlD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000358	0.0029	CcSEcCtD
Telaprevir—Urinary tract disorder—Methotrexate—colon cancer	0.000358	0.00289	CcSEcCtD
Telaprevir—Urethral disorder—Methotrexate—colon cancer	0.000355	0.00287	CcSEcCtD
Telaprevir—Diarrhoea—Irinotecan—colon cancer	0.000354	0.00286	CcSEcCtD
Telaprevir—Dizziness—Vincristine—colon cancer	0.000351	0.00284	CcSEcCtD
Telaprevir—Pruritus—Fluorouracil—colon cancer	0.00035	0.00283	CcSEcCtD
Telaprevir—Infection—Capecitabine—colon cancer	0.000344	0.00278	CcSEcCtD
Telaprevir—Erythema multiforme—Methotrexate—colon cancer	0.000343	0.00277	CcSEcCtD
Telaprevir—Dizziness—Irinotecan—colon cancer	0.000342	0.00276	CcSEcCtD
Telaprevir—Shock—Capecitabine—colon cancer	0.00034	0.00275	CcSEcCtD
Telaprevir—Nervous system disorder—Capecitabine—colon cancer	0.000339	0.00274	CcSEcCtD
Telaprevir—Eye disorder—Methotrexate—colon cancer	0.000339	0.00274	CcSEcCtD
Telaprevir—Diarrhoea—Fluorouracil—colon cancer	0.000339	0.00274	CcSEcCtD
Telaprevir—Thrombocytopenia—Capecitabine—colon cancer	0.000339	0.00274	CcSEcCtD
Telaprevir—Vomiting—Vincristine—colon cancer	0.000337	0.00273	CcSEcCtD
Telaprevir—Skin disorder—Capecitabine—colon cancer	0.000336	0.00272	CcSEcCtD
Telaprevir—Rash—Vincristine—colon cancer	0.000335	0.0027	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—colon cancer	0.000334	0.0027	CcSEcCtD
Telaprevir—Vomiting—Irinotecan—colon cancer	0.000329	0.00266	CcSEcCtD
Telaprevir—Dizziness—Fluorouracil—colon cancer	0.000327	0.00265	CcSEcCtD
Telaprevir—Rash—Irinotecan—colon cancer	0.000326	0.00263	CcSEcCtD
Telaprevir—Dermatitis—Irinotecan—colon cancer	0.000325	0.00263	CcSEcCtD
Telaprevir—Malnutrition—Methotrexate—colon cancer	0.000315	0.00255	CcSEcCtD
Telaprevir—Nausea—Vincristine—colon cancer	0.000315	0.00255	CcSEcCtD
Telaprevir—Vomiting—Fluorouracil—colon cancer	0.000315	0.00254	CcSEcCtD
Telaprevir—Rash—Fluorouracil—colon cancer	0.000312	0.00252	CcSEcCtD
Telaprevir—Dermatitis—Fluorouracil—colon cancer	0.000312	0.00252	CcSEcCtD
Telaprevir—Dysgeusia—Methotrexate—colon cancer	0.000309	0.0025	CcSEcCtD
Telaprevir—Nausea—Irinotecan—colon cancer	0.000307	0.00248	CcSEcCtD
Telaprevir—ABCB1—liver—colon cancer	0.000305	0.00257	CbGeAlD
Telaprevir—CMA1—ACE Inhibitor Pathway—TGFB1—colon cancer	0.0003	0.0524	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000299	0.00241	CcSEcCtD
Telaprevir—Fatigue—Capecitabine—colon cancer	0.000298	0.00241	CcSEcCtD
Telaprevir—Nausea—Fluorouracil—colon cancer	0.000294	0.00238	CcSEcCtD
Telaprevir—Anaemia—Methotrexate—colon cancer	0.000292	0.00236	CcSEcCtD
Telaprevir—Urticaria—Capecitabine—colon cancer	0.000275	0.00222	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000267	0.00216	CcSEcCtD
Telaprevir—Infection—Methotrexate—colon cancer	0.000256	0.00207	CcSEcCtD
Telaprevir—Nervous system disorder—Methotrexate—colon cancer	0.000252	0.00204	CcSEcCtD
Telaprevir—Thrombocytopenia—Methotrexate—colon cancer	0.000252	0.00204	CcSEcCtD
Telaprevir—Skin disorder—Methotrexate—colon cancer	0.00025	0.00202	CcSEcCtD
Telaprevir—Asthenia—Capecitabine—colon cancer	0.000248	0.00201	CcSEcCtD
Telaprevir—Pruritus—Capecitabine—colon cancer	0.000245	0.00198	CcSEcCtD
Telaprevir—Diarrhoea—Capecitabine—colon cancer	0.000237	0.00191	CcSEcCtD
Telaprevir—ABCB1—lymph node—colon cancer	0.000234	0.00197	CbGeAlD
Telaprevir—Dizziness—Capecitabine—colon cancer	0.000229	0.00185	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000222	0.0018	CcSEcCtD
Telaprevir—Fatigue—Methotrexate—colon cancer	0.000222	0.00179	CcSEcCtD
Telaprevir—Vomiting—Capecitabine—colon cancer	0.00022	0.00178	CcSEcCtD
Telaprevir—Rash—Capecitabine—colon cancer	0.000218	0.00176	CcSEcCtD
Telaprevir—Dermatitis—Capecitabine—colon cancer	0.000218	0.00176	CcSEcCtD
Telaprevir—Nausea—Capecitabine—colon cancer	0.000205	0.00166	CcSEcCtD
Telaprevir—Urticaria—Methotrexate—colon cancer	0.000205	0.00165	CcSEcCtD
Telaprevir—Asthenia—Methotrexate—colon cancer	0.000185	0.00149	CcSEcCtD
Telaprevir—Pruritus—Methotrexate—colon cancer	0.000182	0.00147	CcSEcCtD
Telaprevir—Diarrhoea—Methotrexate—colon cancer	0.000176	0.00142	CcSEcCtD
Telaprevir—Dizziness—Methotrexate—colon cancer	0.00017	0.00138	CcSEcCtD
Telaprevir—Vomiting—Methotrexate—colon cancer	0.000164	0.00132	CcSEcCtD
Telaprevir—Rash—Methotrexate—colon cancer	0.000162	0.00131	CcSEcCtD
Telaprevir—Dermatitis—Methotrexate—colon cancer	0.000162	0.00131	CcSEcCtD
Telaprevir—Nausea—Methotrexate—colon cancer	0.000153	0.00124	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—CDH1—colon cancer	0.000134	0.0234	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—CDH1—colon cancer	0.000119	0.0208	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—SRC—colon cancer	0.000117	0.0204	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—FGFR3—colon cancer	0.000109	0.0192	CbGpPWpGaD
Telaprevir—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000103	0.0181	CbGpPWpGaD
Telaprevir—CMA1—Peptide hormone metabolism—CTNNB1—colon cancer	0.000102	0.0179	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—CASP3—colon cancer	0.000102	0.0179	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CDX2—colon cancer	9.82e-05	0.0172	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—CDH1—colon cancer	9.81e-05	0.0172	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—CASP3—colon cancer	9.12e-05	0.016	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MUC2—colon cancer	8.35e-05	0.0146	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—colon cancer	7.83e-05	0.0137	CbGpPWpGaD
Telaprevir—CTSS—Degradation of the extracellular matrix—CASP3—colon cancer	7.51e-05	0.0131	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—colon cancer	7.26e-05	0.0127	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	7.21e-05	0.0126	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—BCL10—colon cancer	7.05e-05	0.0123	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—DLC1—colon cancer	6.85e-05	0.012	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—BCL10—colon cancer	6.77e-05	0.0118	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—CDKN1A—colon cancer	6.67e-05	0.0117	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—LGR5—colon cancer	6.44e-05	0.0113	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—SRC—colon cancer	6.17e-05	0.0108	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—NRAS—colon cancer	5.94e-05	0.0104	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—BCL10—colon cancer	5.81e-05	0.0102	CbGpPWpGaD
Telaprevir—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	5.65e-05	0.00988	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—CDH1—colon cancer	5.6e-05	0.0098	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—BCL10—colon cancer	5.58e-05	0.00976	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—colon cancer	5.41e-05	0.00946	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—KRAS—colon cancer	5.11e-05	0.00894	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—CDH1—colon cancer	4.99e-05	0.00873	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	4.96e-05	0.00868	CbGpPWpGaD
Telaprevir—CYP3A4—Irinotecan Pathway—APC—colon cancer	4.75e-05	0.00832	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—PIK3CA—colon cancer	4.7e-05	0.00821	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AXIN2—colon cancer	4.62e-05	0.00809	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—HRAS—colon cancer	4.34e-05	0.0076	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—CASP3—colon cancer	4.29e-05	0.0075	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CDH1—colon cancer	4.11e-05	0.00719	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BCL10—colon cancer	4.11e-05	0.00719	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—AKT1—colon cancer	3.84e-05	0.00671	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—CASP3—colon cancer	3.82e-05	0.00669	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CD8A—colon cancer	3.71e-05	0.00649	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	3.69e-05	0.00646	CbGpPWpGaD
Telaprevir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.66e-05	0.00641	CbGpPWpGaD
Telaprevir—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	3.4e-05	0.00595	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BCL10—colon cancer	3.38e-05	0.00592	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—TGFB1—colon cancer	3.34e-05	0.00584	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	3.31e-05	0.00579	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—BCL2L1—colon cancer	3.31e-05	0.00578	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	3.24e-05	0.00567	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—FGFR3—colon cancer	3.16e-05	0.00553	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—CASP3—colon cancer	3.15e-05	0.00551	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CD8A—colon cancer	3.06e-05	0.00535	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—FGFR3—colon cancer	3.04e-05	0.00531	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—TGFB1—colon cancer	2.98e-05	0.00521	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—BCL2L1—colon cancer	2.72e-05	0.00476	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—FGFR3—colon cancer	2.6e-05	0.00455	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDH1—colon cancer	2.56e-05	0.00449	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	2.52e-05	0.00441	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FGFR3—colon cancer	2.5e-05	0.00437	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—TGFB1—colon cancer	2.45e-05	0.00429	CbGpPWpGaD
Telaprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.26e-05	0.00395	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD8A—colon cancer	2.25e-05	0.00394	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	2.12e-05	0.00371	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDH1—colon cancer	2.11e-05	0.00369	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CTNNB1—colon cancer	1.97e-05	0.00345	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CTNNB1—colon cancer	1.93e-05	0.00338	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CDKN1A—colon cancer	1.93e-05	0.00337	CbGpPWpGaD
Telaprevir—CTSK—Immune System—BCL2L1—colon cancer	1.93e-05	0.00337	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD8A—colon cancer	1.85e-05	0.00324	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CDKN1A—colon cancer	1.85e-05	0.00323	CbGpPWpGaD
Telaprevir—CTSK—Immune System—FGFR3—colon cancer	1.84e-05	0.00322	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EP300—colon cancer	1.83e-05	0.00321	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—SRC—colon cancer	1.78e-05	0.00312	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CA7—colon cancer	1.75e-05	0.00307	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—colon cancer	1.71e-05	0.003	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SRC—colon cancer	1.71e-05	0.00299	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.7e-05	0.00297	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—colon cancer	1.65e-05	0.00288	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—colon cancer	1.62e-05	0.00284	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CDKN1A—colon cancer	1.59e-05	0.00277	CbGpPWpGaD
Telaprevir—CTSS—Immune System—BCL2L1—colon cancer	1.59e-05	0.00277	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—colon cancer	1.56e-05	0.00273	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.56e-05	0.00273	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—colon cancer	1.56e-05	0.00272	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CA7—colon cancer	1.54e-05	0.00269	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.54e-05	0.00269	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1A—colon cancer	1.52e-05	0.00266	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FGFR3—colon cancer	1.52e-05	0.00265	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EP300—colon cancer	1.51e-05	0.00264	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—colon cancer	1.5e-05	0.00262	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—colon cancer	1.48e-05	0.00258	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—SRC—colon cancer	1.47e-05	0.00257	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—colon cancer	1.42e-05	0.00248	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—colon cancer	1.41e-05	0.00247	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.41e-05	0.00247	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SRC—colon cancer	1.41e-05	0.00246	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP3—colon cancer	1.36e-05	0.00238	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—colon cancer	1.36e-05	0.00237	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—colon cancer	1.36e-05	0.00237	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.34e-05	0.00235	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FGFR3—colon cancer	1.34e-05	0.00234	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.33e-05	0.00233	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—colon cancer	1.31e-05	0.00228	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—colon cancer	1.3e-05	0.00228	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.3e-05	0.00227	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—colon cancer	1.29e-05	0.00225	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—colon cancer	1.28e-05	0.00224	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—colon cancer	1.25e-05	0.00219	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.25e-05	0.00219	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.24e-05	0.00218	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—colon cancer	1.24e-05	0.00216	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APC—colon cancer	1.23e-05	0.00214	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—colon cancer	1.22e-05	0.00213	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—colon cancer	1.2e-05	0.00211	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—TGFB1—colon cancer	1.2e-05	0.0021	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—colon cancer	1.17e-05	0.00204	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.16e-05	0.00202	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—BRAF—colon cancer	1.15e-05	0.00202	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—colon cancer	1.15e-05	0.00201	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—colon cancer	1.15e-05	0.00201	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.14e-05	0.002	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1A—colon cancer	1.12e-05	0.00196	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—colon cancer	1.12e-05	0.00195	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AKT1—colon cancer	1.11e-05	0.00194	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—colon cancer	1.07e-05	0.00188	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EP300—colon cancer	1.07e-05	0.00187	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—AKT1—colon cancer	1.06e-05	0.00186	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CHST5—colon cancer	1.06e-05	0.00186	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ODC1—colon cancer	1.06e-05	0.00186	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.06e-05	0.00186	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SRC—colon cancer	1.04e-05	0.00182	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—colon cancer	1.03e-05	0.00181	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—colon cancer	9.99e-06	0.00175	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—colon cancer	9.92e-06	0.00173	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.54e-06	0.00167	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CA7—colon cancer	9.47e-06	0.00166	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—colon cancer	9.46e-06	0.00165	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CHST5—colon cancer	9.31e-06	0.00163	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ODC1—colon cancer	9.31e-06	0.00163	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1A—colon cancer	9.24e-06	0.00162	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—colon cancer	9.12e-06	0.0016	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—colon cancer	9.1e-06	0.00159	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EP300—colon cancer	8.79e-06	0.00154	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—colon cancer	8.76e-06	0.00153	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—colon cancer	8.64e-06	0.00151	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—colon cancer	8.59e-06	0.0015	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SRC—colon cancer	8.55e-06	0.0015	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	8.52e-06	0.00149	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—colon cancer	8.41e-06	0.00147	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—colon cancer	8.33e-06	0.00146	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—colon cancer	8.22e-06	0.00144	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1A—colon cancer	8.14e-06	0.00142	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—colon cancer	7.9e-06	0.00138	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EP300—colon cancer	7.74e-06	0.00135	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—colon cancer	7.53e-06	0.00132	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—colon cancer	7.49e-06	0.00131	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—colon cancer	7.33e-06	0.00128	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—colon cancer	7.31e-06	0.00128	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—colon cancer	7.24e-06	0.00127	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.24e-06	0.00127	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—colon cancer	7.08e-06	0.00124	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—colon cancer	6.75e-06	0.00118	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TGFB1—colon cancer	6.73e-06	0.00118	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.72e-06	0.00118	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—colon cancer	6.6e-06	0.00115	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.54e-06	0.00114	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—colon cancer	6.5e-06	0.00114	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.48e-06	0.00113	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—colon cancer	6.45e-06	0.00113	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.33e-06	0.00111	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—colon cancer	6.23e-06	0.00109	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.02e-06	0.00105	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—colon cancer	6.02e-06	0.00105	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	6e-06	0.00105	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	5.95e-06	0.00104	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.86e-06	0.00102	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	5.79e-06	0.00101	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ODC1—colon cancer	5.74e-06	0.001	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CHST5—colon cancer	5.74e-06	0.001	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—colon cancer	5.73e-06	0.001	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.71e-06	0.000998	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—colon cancer	5.54e-06	0.000969	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	5.32e-06	0.00093	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—colon cancer	5.31e-06	0.000929	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—colon cancer	5.3e-06	0.000927	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.25e-06	0.000918	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.24e-06	0.000916	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.13e-06	0.000898	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.85e-06	0.000848	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—colon cancer	4.68e-06	0.000818	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	4.53e-06	0.000792	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.46e-06	0.000779	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.39e-06	0.000768	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.31e-06	0.000754	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.7e-06	0.000647	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.64e-06	0.000637	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.45e-06	0.000604	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—colon cancer	3.15e-06	0.000552	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—colon cancer	3.07e-06	0.000536	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—colon cancer	2.99e-06	0.000522	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—colon cancer	2.95e-06	0.000516	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.87e-06	0.000502	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—colon cancer	2.81e-06	0.000491	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—colon cancer	2.76e-06	0.000483	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—colon cancer	2.74e-06	0.000479	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—colon cancer	2.54e-06	0.000444	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—colon cancer	2.42e-06	0.000423	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—colon cancer	2.33e-06	0.000408	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—colon cancer	2.26e-06	0.000395	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—colon cancer	2.16e-06	0.000377	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.12e-06	0.000371	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—colon cancer	1.95e-06	0.000342	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—colon cancer	1.91e-06	0.000333	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—colon cancer	1.71e-06	0.000299	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—colon cancer	1.54e-06	0.000269	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—colon cancer	1.52e-06	0.000265	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—colon cancer	1.49e-06	0.00026	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—colon cancer	1.35e-06	0.000236	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—colon cancer	1.28e-06	0.000224	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—colon cancer	1.12e-06	0.000196	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—colon cancer	1.05e-06	0.000185	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—colon cancer	9.46e-07	0.000165	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—colon cancer	8.3e-07	0.000145	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—colon cancer	8.29e-07	0.000145	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—colon cancer	7.73e-07	0.000135	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—colon cancer	6.9e-07	0.000121	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—colon cancer	6.77e-07	0.000118	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—colon cancer	5.11e-07	8.93e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—colon cancer	4.17e-07	7.3e-05	CbGpPWpGaD
